Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001964306-25-000142
Filing Date
2025-03-07
Accepted
2025-03-07 16:32:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3545
  Complete submission text file 0001964306-25-000142.txt   5013
Mailing Address 202 CARNEGIE CENTER SUITE 301 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 301 PRINCETON NJ 08540 646-885-8505
Y-mAbs Therapeutics, Inc. (Subject) CIK: 0001722964 (see all company filings)

EIN.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38650 | Film No.: 25720636
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE, 33RD FLOOR NEW YORK NY 10169
Business Address
Gad Thomas (Reporting) CIK: 0001753224 (see all company filings)

Type: 144